Labcorp Holdings Inc. vs Abbvie Inc.
LH vs ABBV — side-by-side comparison from reported financials. LH leads 6, ABBV leads 6 of 12 comparable metrics.
Labcorp Holdings Inc.
LH · Healthcare
$311.84-0.75%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | LH | ABBV |
|---|---|---|
| Price | $311.84 | $276.43 |
| Market cap | $25.3B | $488B |
| Revenue (TTM) | $14.3B | $64.4B |
| Revenue growth | +5.5% | +1.8% |
| Net margin | 7.0% | 9.8% |
| Free cash flow | $1.16B | $18.2B |
| Net cash (debt) | ($4.55B) | ($56.2B) |
| 1-year price return | +12.3% | +19.8% |
| P/E | 25.3 | 77.4 |
| P/E vs own history (cheap-side %) | 51% | 23% |
| Dividend yield | 0.94% | 2.45% |
| Return on equity | 12% | 96% |
| Altman Z-score | 2.86 | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 71,000 | 57,000 |
Full résumé-style profiles: LH CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.